
Hepatobiliary cancers and immunotherapy: where are we now and where are we heading?
Author(s) -
Adam Zayac,
Khaldoun Almhanna
Publication year - 2020
Publication title -
translational gastroenterology and hepatology
Language(s) - English
Resource type - Journals
ISSN - 2415-1289
DOI - 10.21037/tgh.2019.09.07
Subject(s) - pembrolizumab , medicine , nivolumab , intrahepatic cholangiocarcinoma , lenvatinib , oncology , microsatellite instability , gallbladder cancer , cancer , hepatocellular carcinoma , immunotherapy , sorafenib , allele , biochemistry , chemistry , microsatellite , gene